Preferred Label : PRT064445;

MeSH note : a modified version of recombinant factor Xa that does not contribute to blood clotting and can reverse the effect of factor Xa inhibitors;

Is substance : O;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
andexanet alfa
andexanet alfa
hemorrhage
hemorrhage
apixaban
Rivaroxaban
antidotes
antidotes
adult
infusions, intravenous
Factor Xa Inhibitors
andexanet alfa
product surveillance, postmarketing
pregnancy
breast feeding
Anticoagulant reversal therapy
PRT064445
PRT064445
recombinant proteins
factor xa
recombinant proteins
factor xa
pyrazoles
pyridones

---
Nous contacter.
01/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.